Drawing for Serial No. 79401210

USPTO serial 79401210

Serial No. 79401210

Reviewed by CopyMark Law Group

Reg. 8122382Status 700Registered
Filing date
Status date
Registration date
Feb 3, 2026
Examiner
FICKES, JERI J
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with Serial No. 79401210?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Yue (Robert) Xu

Yue (Robert) Xu Apex Attorneys at Law, LLP160 Alamo Plaza #942Alamo, CA 94507United States

Goods and services

ClassDescriptionStatusFirst use
005Medicines for use in the treatment of sexual disorder, impotence, male sterility, gynaecological disease, nervous system, digestive system, respiratory system, cold, cough, sour stomach, and cold prevention for human purposes; drugs, namely, pharmaceutical preparations for use in the management of nausea and vomiting, in the treatment of irregular menstruation, edema, lowing blood sugar and blood fat, sexual disorder, impotence, male sterility, gynaecological disease, nervous system, digestive system, respiratory system, cold, cough, sour stomach, and cold prevention; medicinal drinks, namely, medicinal liquor; medicines made of Chinese traditional medicinal herbs; herbal teas for medicinal purposes; medicinal tea; medical dressings; nutritional supplements for medical purposes; nutritionally fortified beverages for medical purposes; nutritional supplements; decoctions of medicinal herb for use in the management of nausea and vomiting, in the treatment of irregular menstruation, edema, lowing blood sugar and blood fat, sexual disorder, impotence, male sterility, gynaecological disease, nervous system, digestive system, respiratory system, cold, cough, sour stomach, and cold prevention; moxa rolls for moxibustionACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 27, 2026FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Aug 6, 2026FICSFINAL DISPOSITION NOTICE SENT TO IB—
Aug 6, 2026FIMPFINAL DISPOSITION PROCESSED—
May 3, 2026FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Feb 3, 2026NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Feb 3, 2026R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 15, 2026OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Dec 31, 2025OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Dec 31, 2025OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Dec 16, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Dec 16, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 10, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Nov 20, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 20, 2025XAECEXAMINER'S AMENDMENT ENTERED—
Nov 20, 2025GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Nov 20, 2025GNEAEXAMINERS AMENDMENT E-MAILED—
Nov 20, 2025CNEAEXAMINERS AMENDMENT -WRITTEN—
May 8, 2025GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
May 8, 2025GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
May 8, 2025CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Apr 17, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 17, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 17, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 5, 2025RFNTREFUSAL PROCESSED BY IB—
Dec 13, 2024RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Dec 13, 2024RFRRREFUSAL PROCESSED BY MPU—
Nov 30, 2024RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Nov 29, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 21, 2024DOCKASSIGNED TO EXAMINER—
Aug 5, 2024MAFRAPPLICATION FILING RECEIPT MAILED—
Aug 5, 2024NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 1, 2024REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance